Researchers say they saw success in an early trial of a vaccine for the most common bacterial sexually transmitted infection in the world.
There are 131 million new cases of chlamydia every year worldwide, Imperial College London reports in a release about the study. They note that number could be on the low side, because many cases are symptomless and go undetected. Although treatments are already available for chlamydia, the press release notes that antibiotics and national treatment programs haven’t been able to effectively fight the number of chlamydia cases reported every year on a global scale.
“The major issue with chlamydia is the long-term consequences,” Professor Shattock said. “It is very treatable if identified, but, as many people don’t have symptoms, it can be missed.” Shattock noted that it can contribute to
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
A chlamydia vaccine shows signs of success in an early trialScientists have taken a step towards a vaccine for chlamydia following a successful early trial.
Baca lebih lajut »
https://time.comBreaking news and analysis from TIME.com. Politics, world news, photos, video, tech reviews, health, science and entertainment news.
Baca lebih lajut »
https://people.comGet the latest news about celebrities, royals, music, TV, and real people. Find exclusive content, including photos and videos, on PEOPLE.com.
Baca lebih lajut »
A Vaccine For Our Most Common STI May Be Getting CloserA potential vaccine for chlamydia, which infects millions each year, has passed an important early test on the road to availability:
Baca lebih lajut »
A vaccine that may prevent chlamydia is being tested in peopleThe first chlamydia vaccine to be tested in humans shows shown to be safe and may protect against the bacterial infection.
Baca lebih lajut »
MAGIC Shifting Venue, Dates in FebruaryThe early dates mean the trade shows will once again coincide with New York Fashion Week.
Baca lebih lajut »